4//SEC Filing
Michaelson Jennifer 4
Accession 0000950170-24-082485
CIK 0001789972other
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 5:30 PM ET
Size
5.4 KB
Accession
0000950170-24-082485
Insider Transaction Report
Form 4
Michaelson Jennifer
Chief Scientific Officer
Transactions
- Sale
Common Stock
2024-07-05$16.33/sh−8,000$130,640→ 123,942 total
Footnotes (2)
- [F1]Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on January 5, 2024.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.97 to $16.77. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Cullinan Therapeutics, Inc.
CIK 0001789972
Entity typeother
Related Parties
1- filerCIK 0001838061
Filing Metadata
- Form type
- 4
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 5:30 PM ET
- Size
- 5.4 KB